Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Zinc Acetate Potentiates the Action of Tosufloxacin against Escherichia coli Biofilm Persisters.

Usui M, Yokoo H, Tamura Y, Nakajima C, Suzuki Y, Ghigo JM, Beloin C.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00069-19. doi: 10.1128/AAC.00069-19. Print 2019 Jun.

PMID:
30936108
2.

A putative type V pilus contributes to Bacteroides thetaiotaomicron biofilm formation capacity.

Mihajlovic J, Bechon N, Ivanova C, Chain F, Almeida A, Langella P, Beloin C, Ghigo JM.

J Bacteriol. 2019 Mar 4. pii: JB.00650-18. doi: 10.1128/JB.00650-18. [Epub ahead of print]

PMID:
30833358
3.

Long-term stability of gentamicin sulfate-ethylenediaminetetraacetic acid disodium salt (EDTA-Na2) solution for catheter locks.

Fiolet AS, Jandot E, Doucey P, Crétet C, Brunel C, Pivot C, Ghigo JM, Beloin C, Lebeaux D, Pirot F.

J Pharm Anal. 2018 Dec;8(6):386-393. doi: 10.1016/j.jpha.2017.09.004. Epub 2017 Sep 25.

4.

Increased Osmolarity in Biofilm Triggers RcsB-Dependent Lipid A Palmitoylation in Escherichia coli.

Szczesny M, Beloin C, Ghigo JM.

MBio. 2018 Aug 21;9(4). pii: e01415-18. doi: 10.1128/mBio.01415-18.

5.

Probing the influence of cell surface polysaccharides on nanodendrimer binding to Gram-negative and Gram-positive bacteria using single-nanoparticle force spectroscopy.

Beaussart A, Beloin C, Ghigo JM, Chapot-Chartier MP, Kulakauskas S, Duval JFL.

Nanoscale. 2018 Jul 9;10(26):12743-12753. doi: 10.1039/c8nr01766b.

PMID:
29946619
6.

Asymmetric adhesion of rod-shaped bacteria controls microcolony morphogenesis.

Duvernoy MC, Mora T, Ardré M, Croquette V, Bensimon D, Quilliet C, Ghigo JM, Balland M, Beloin C, Lecuyer S, Desprat N.

Nat Commun. 2018 Mar 16;9(1):1120. doi: 10.1038/s41467-018-03446-y.

7.

Comparative Analysis of Bacterial Community Composition and Structure in Clinically Symptomatic and Asymptomatic Central Venous Catheters.

Stressmann FA, Couve-Deacon E, Chainier D, Chauhan A, Wessel A, Durand-Fontanier S, Escande MC, Kriegel I, Francois B, Ploy MC, Beloin C, Ghigo JM.

mSphere. 2017 Sep 27;2(5). pii: e00146-17. doi: 10.1128/mSphere.00146-17. eCollection 2017 Sep-Oct.

8.

YeeJ is an inverse autotransporter from Escherichia coli that binds to peptidoglycan and promotes biofilm formation.

Martinez-Gil M, Goh KGK, Rackaityte E, Sakamoto C, Audrain B, Moriel DG, Totsika M, Ghigo JM, Schembri MA, Beloin C.

Sci Rep. 2017 Sep 12;7(1):11326. doi: 10.1038/s41598-017-10902-0.

9.

Outer Membrane Proteome of Veillonella parvula: A Diderm Firmicute of the Human Microbiome.

Poppleton DI, Duchateau M, Hourdel V, Matondo M, Flechsler J, Klingl A, Beloin C, Gribaldo S.

Front Microbiol. 2017 Jun 30;8:1215. doi: 10.3389/fmicb.2017.01215. eCollection 2017.

10.

Central venous catheters and biofilms: where do we stand in 2017?

Gominet M, Compain F, Beloin C, Lebeaux D.

APMIS. 2017 Apr;125(4):365-375. doi: 10.1111/apm.12665. Review.

PMID:
28407421
11.

Functional analysis of Escherichia coli Yad fimbriae reveals their potential role in environmental persistence.

Larsonneur F, Martin FA, Mallet A, Martinez-Gil M, Semetey V, Ghigo JM, Beloin C.

Environ Microbiol. 2016 Dec;18(12):5228-5248. doi: 10.1111/1462-2920.13559. Epub 2016 Oct 24.

PMID:
27696649
12.

Phylogenomic analysis supports the ancestral presence of LPS-outer membranes in the Firmicutes.

Antunes LC, Poppleton D, Klingl A, Criscuolo A, Dupuy B, Brochier-Armanet C, Beloin C, Gribaldo S.

Elife. 2016 Aug 31;5. pii: e14589. doi: 10.7554/eLife.14589.

13.

Understanding biofilm formation in intravascular device-related infections.

Beloin C, Fernández-Hidalgo N, Lebeaux D.

Intensive Care Med. 2017 Mar;43(3):443-446. doi: 10.1007/s00134-016-4480-7. Epub 2016 Aug 6. No abstract available.

14.

Impact of percutaneous pulmonary valve implantation procedural steps on leaflets histology and mechanical behaviour: An in vitro study.

Jalal Z, Galmiche L, Beloin C, Boudjemline Y.

Arch Cardiovasc Dis. 2016 Aug-Sep;109(8-9):465-75. doi: 10.1016/j.acvd.2016.01.015. Epub 2016 Jun 23.

15.

Study of in vivo catheter biofilm infections using pediatric central venous catheter implanted in rat.

Chauhan A, Ghigo JM, Beloin C.

Nat Protoc. 2016 Mar;11(3):525-41. doi: 10.1038/nprot.2016.033. Epub 2016 Feb 18.

16.

Selective propensity of bovine jugular vein material to bacterial adhesions: An in-vitro study.

Jalal Z, Galmiche L, Lebeaux D, Villemain O, Brugada G, Patel M, Ghigo JM, Beloin C, Boudjemline Y.

Int J Cardiol. 2015 Nov 1;198:201-5. doi: 10.1016/j.ijcard.2015.07.004. Epub 2015 Jul 6.

PMID:
26173058
17.

Dynamic modulation of fimbrial extension and FimH-mannose binding force on live bacteria under pH changes: a molecular atomic force microscopy analysis.

Jacquot A, Sakamoto C, Razafitianamaharavo A, Caillet C, Merlin J, Fahs A, Ghigo JM, Beloin C, Duval JF, Francius G.

J Biomed Nanotechnol. 2014 Nov;10(11):3361-72.

18.
19.

Inhibition of type 1 fimbriae-mediated Escherichia coli adhesion and biofilm formation by trimeric cluster thiomannosides conjugated to diamond nanoparticles.

Khanal M, Larsonneur F, Raks V, Barras A, Baumann JS, Martin FA, Boukherroub R, Ghigo JM, Ortiz Mellet C, Zaitsev V, Garcia Fernandez JM, Beloin C, Siriwardena A, Szunerits S.

Nanoscale. 2015 Feb 14;7(6):2325-35. doi: 10.1039/c4nr05906a.

20.

Novel approaches to combat bacterial biofilms.

Beloin C, Renard S, Ghigo JM, Lebeaux D.

Curr Opin Pharmacol. 2014 Oct;18:61-8. doi: 10.1016/j.coph.2014.09.005. Epub 2014 Sep 23. Review.

21.

The dynamics and pH-dependence of Ag43 adhesins' self-association probed by atomic force spectroscopy.

Jacquot A, Sakamoto C, Razafitianamarahavo A, Caillet C, Merlin J, Fahs A, Ghigo JM, Duval JF, Beloin C, Francius G.

Nanoscale. 2014 Nov 7;6(21):12665-81. doi: 10.1039/c4nr03312d.

22.

Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.

Lebeaux D, Ghigo JM, Beloin C.

Microbiol Mol Biol Rev. 2014 Sep;78(3):510-43. doi: 10.1128/MMBR.00013-14. Review.

23.

Biofilms formed by gram-negative bacteria undergo increased lipid a palmitoylation, enhancing in vivo survival.

Chalabaev S, Chauhan A, Novikov A, Iyer P, Szczesny M, Beloin C, Caroff M, Ghigo JM.

MBio. 2014 Aug 19;5(4). pii: e01116-14. doi: 10.1128/mBio.01116-14.

24.

Bacteria hold their breath upon surface contact as shown in a strain of Escherichia coli, using dispersed surfaces and flow cytometry analysis.

Geng J, Beloin C, Ghigo JM, Henry N.

PLoS One. 2014 Jul 23;9(7):e102049. doi: 10.1371/journal.pone.0102049. eCollection 2014.

25.

pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms.

Lebeaux D, Chauhan A, Létoffé S, Fischer F, de Reuse H, Beloin C, Ghigo JM.

J Infect Dis. 2014 Nov 1;210(9):1357-66. doi: 10.1093/infdis/jiu286. Epub 2014 May 15.

26.

Preventing biofilm formation and associated occlusion by biomimetic glycocalyxlike polymer in central venous catheters.

Chauhan A, Bernardin A, Mussard W, Kriegel I, Estève M, Ghigo JM, Beloin C, Semetey V.

J Infect Dis. 2014 Nov 1;210(9):1347-56. doi: 10.1093/infdis/jiu249. Epub 2014 May 1.

27.

In vitro activities of dermaseptins K4S4 and K4K20S4 against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa planktonic growth and biofilm formation.

Zaïri A, Ferrières L, Latour-Lambert P, Beloin C, Tangy F, Ghigo JM, Hani K.

Antimicrob Agents Chemother. 2014;58(4):2221-8. doi: 10.1128/AAC.02142-13. Epub 2014 Feb 3.

28.

A new biofilm-associated colicin with increased efficiency against biofilm bacteria.

Rendueles O, Beloin C, Latour-Lambert P, Ghigo JM.

ISME J. 2014 Jun;8(6):1275-88. doi: 10.1038/ismej.2013.238. Epub 2014 Jan 23.

29.

Management of infections related to totally implantable venous-access ports: challenges and perspectives.

Lebeaux D, Fernández-Hidalgo N, Chauhan A, Lee S, Ghigo JM, Almirante B, Beloin C.

Lancet Infect Dis. 2014 Feb;14(2):146-59. doi: 10.1016/S1473-3099(13)70266-4. Epub 2013 Dec 5. Review.

30.

Induction of the Cpx envelope stress pathway contributes to Escherichia coli tolerance to antimicrobial peptides.

Audrain B, Ferrières L, Zairi A, Soubigou G, Dobson C, Coppée JY, Beloin C, Ghigo JM.

Appl Environ Microbiol. 2013 Dec;79(24):7770-9. doi: 10.1128/AEM.02593-13. Epub 2013 Oct 4.

31.

Did I pick the right colony? Pitfalls in the study of regulation of the phase variable antigen 43 adhesin.

Chauhan A, Sakamoto C, Ghigo JM, Beloin C.

PLoS One. 2013 Sep 5;8(9):e73568. doi: 10.1371/journal.pone.0073568. eCollection 2013.

32.

Sugar-modified foldamers as conformationally defined and biologically distinct glycopeptide mimics.

Siriwardena A, Pulukuri KK, Kandiyal PS, Roy S, Bande O, Ghosh S, Garcia Fernández JM, Martin FA, Ghigo JM, Beloin C, Ito K, Woods RJ, Ampapathi RS, Chakraborty TK.

Angew Chem Int Ed Engl. 2013 Sep 23;52(39):10221-6. doi: 10.1002/anie.201304239. Epub 2013 Aug 13. No abstract available.

33.

Identification of commensal Escherichia coli genes involved in biofilm resistance to pathogen colonization.

Da Re S, Valle J, Charbonnel N, Beloin C, Latour-Lambert P, Faure P, Turlin E, Le Bouguénec C, Renauld-Mongénie G, Forestier C, Ghigo JM.

PLoS One. 2013 May 7;8(5):e61628. doi: 10.1371/journal.pone.0061628. Print 2013.

34.

Glycan-functionalized diamond nanoparticles as potent E. coli anti-adhesives.

Barras A, Martin FA, Bande O, Baumann JS, Ghigo JM, Boukherroub R, Beloin C, Siriwardena A, Szunerits S.

Nanoscale. 2013 Mar 21;5(6):2307-16. doi: 10.1039/c3nr33826f.

PMID:
23396565
35.

Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin.

Bernier SP, Lebeaux D, DeFrancesco AS, Valomon A, Soubigou G, Coppée JY, Ghigo JM, Beloin C.

PLoS Genet. 2013;9(1):e1003144. doi: 10.1371/journal.pgen.1003144. Epub 2013 Jan 3.

36.

From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.

Lebeaux D, Chauhan A, Rendueles O, Beloin C.

Pathogens. 2013 May 13;2(2):288-356. doi: 10.3390/pathogens2020288. Review.

37.

Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy.

Chauhan A, Lebeaux D, Ghigo JM, Beloin C.

Antimicrob Agents Chemother. 2012 Dec;56(12):6310-8. doi: 10.1128/AAC.01606-12. Epub 2012 Oct 1.

38.

Mapping of bacterial biofilm local mechanics by magnetic microparticle actuation.

Galy O, Latour-Lambert P, Zrelli K, Ghigo JM, Beloin C, Henry N.

Biophys J. 2012 Sep 19;103(6):1400-8. doi: 10.1016/j.bpj.2012.07.001.

39.

Functional heterogeneity of the UpaH autotransporter protein from uropathogenic Escherichia coli.

Allsopp LP, Beloin C, Moriel DG, Totsika M, Ghigo JM, Schembri MA.

J Bacteriol. 2012 Nov;194(21):5769-82. doi: 10.1128/JB.01264-12. Epub 2012 Aug 17.

40.

A rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections.

Chauhan A, Lebeaux D, Decante B, Kriegel I, Escande MC, Ghigo JM, Beloin C.

PLoS One. 2012;7(5):e37281. doi: 10.1371/journal.pone.0037281. Epub 2012 May 16.

41.

Molecular characterization of the EhaG and UpaG trimeric autotransporter proteins from pathogenic Escherichia coli.

Totsika M, Wells TJ, Beloin C, Valle J, Allsopp LP, King NP, Ghigo JM, Schembri MA.

Appl Environ Microbiol. 2012 Apr;78(7):2179-89. doi: 10.1128/AEM.06680-11. Epub 2012 Jan 27.

42.

Molecular characterization of UpaB and UpaC, two new autotransporter proteins of uropathogenic Escherichia coli CFT073.

Allsopp LP, Beloin C, Ulett GC, Valle J, Totsika M, Sherlock O, Ghigo JM, Schembri MA.

Infect Immun. 2012 Jan;80(1):321-32. doi: 10.1128/IAI.05322-11. Epub 2011 Sep 19.

43.

Bacterial surface appendages strongly impact nanomechanical and electrokinetic properties of Escherichia coli cells subjected to osmotic stress.

Francius G, Polyakov P, Merlin J, Abe Y, Ghigo JM, Merlin C, Beloin C, Duval JF.

PLoS One. 2011;6(5):e20066. doi: 10.1371/journal.pone.0020066. Epub 2011 May 31. Erratum in: PLoS One. 2011;6(7). doi: 10.1371/annotation/2d1cbf5c-d0f0-40c6-8f32-eb034182538c.

45.

Silent mischief: bacteriophage Mu insertions contaminate products of Escherichia coli random mutagenesis performed using suicidal transposon delivery plasmids mobilized by broad-host-range RP4 conjugative machinery.

Ferrières L, Hémery G, Nham T, Guérout AM, Mazel D, Beloin C, Ghigo JM.

J Bacteriol. 2010 Dec;192(24):6418-27. doi: 10.1128/JB.00621-10. Epub 2010 Oct 8.

46.

Escherichia coli K-12 possesses multiple cryptic but functional chaperone-usher fimbriae with distinct surface specificities.

Korea CG, Badouraly R, Prevost MC, Ghigo JM, Beloin C.

Environ Microbiol. 2010 Jul;12(7):1957-77. doi: 10.1111/j.1462-2920.2010.02202.x. Epub 2010 Mar 23.

PMID:
20345943
47.

Biofilm-forming Pseudomonas aeruginosa bacteria undergo lipopolysaccharide structural modifications and induce enhanced inflammatory cytokine response in human monocytes.

Ciornei CD, Novikov A, Beloin C, Fitting C, Caroff M, Ghigo JM, Cavaillon JM, Adib-Conquy M.

Innate Immun. 2010 Oct;16(5):288-301. doi: 10.1177/1753425909341807. Epub 2009 Aug 26.

PMID:
19710099
48.

Impact of rpoS deletion on the proteome of Escherichia coli grown planktonically and as biofilm.

Collet A, Cosette P, Beloin C, Ghigo JM, Rihouey C, Lerouge P, Junter GA, Jouenne T.

J Proteome Res. 2008 Nov;7(11):4659-69. doi: 10.1021/pr8001723. Epub 2008 Oct 1.

PMID:
18826300
49.

A short-time scale colloidal system reveals early bacterial adhesion dynamics.

Beloin C, Houry A, Froment M, Ghigo JM, Henry N.

PLoS Biol. 2008 Jul 8;6(7):e167. doi: 10.1371/journal.pbio.0060167.

50.

Escherichia coli biofilms.

Beloin C, Roux A, Ghigo JM.

Curr Top Microbiol Immunol. 2008;322:249-89. Review.

Supplemental Content

Loading ...
Support Center